MENU

Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial

Brain implant company Paradromics is preparing for human trials, while President Biden's poor debate performance affected health-care stocks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story